Fibrocell
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Fibrocell and buy or sell other stocks, ETFs, and their options commission-free!About FCSC
Fibrocell Science, Inc. is an autologous cell and gene therapy company, which focuses on translating personalized biologics into medical breakthroughs for diseases affecting the skin and connective tissue. The company was founded on September 28, 1992 and is headquartered in Exton, PA.
CEOJohn M. Maslowski
CEOJohn M. Maslowski
Employees—
Employees—
HeadquartersExton, Pennsylvania
HeadquartersExton, Pennsylvania
Founded1995
Founded1995
Employees—
Employees—
FCSC Key Statistics
Market cap29.27M
Market cap29.27M
Price-Earnings ratio-12.91
Price-Earnings ratio-12.91
Dividend yield—
Dividend yield—
Average volume66.51K
Average volume66.51K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$3.28
52 Week high$3.28
52 Week low$1.45
52 Week low$1.45
Stock Snapshot
The current Fibrocell(FCSC) stock price is $3.00, with a market capitalization of 29.27M. The stock trades at a price-to-earnings (P/E) ratio of -12.91.
Fibrocell(FCSC) stock opened on 2025-12-04 at —. The price climbed to — and dipped to —.
Fibrocell(FCSC) shares are trading with a volume of 0, against a daily average of 66.51K.
During the past year, Fibrocell(FCSC) stock moved between $1.45 at its lowest and $3.28 at its peak.
During the past year, Fibrocell(FCSC) stock moved between $1.45 at its lowest and $3.28 at its peak.